The Role of Low Global Warming Potential Propellants on Suspension Metered Dose Inhaler Sprays
- PMID: 40457138
- DOI: 10.1208/s12249-025-03147-y
The Role of Low Global Warming Potential Propellants on Suspension Metered Dose Inhaler Sprays
Abstract
The reformulation of suspension-based pressurized metered dose inhalers (pMDI) with low global warming potential (GWP) propellants is challenged by wide-ranging changes to their chemicophysical properties such as vapor pressure, density and latent heat. The effect of low-GWP propellants on spray pattern and plume geometry for suspension pMDIs are not fully understood. There is a lack of data regarding the role of propellant choice and potential interactions with suspended drugs, which may explain performance variations between products and guide development of in-silico models. In this study, high speed imaging was used to measure the plume morphology and optical density of sprays containing HFA134a, HFA152a and HFO1234ze(E) propellants. Propellant-only placebo controls were compared to suspension formulations containing 2 mg/mL salbutamol sulphate. It was found that the presence of suspended particles has a significant effect on plume structure, reducing correlations between propellant thermophysical properties and cone angle, targeting angle, and optical center of mass by 6-7 times. These effects vary depending on propellant type due to variations in flash-evaporation behavior, which is less pronounced in low-GWP propellants compared to HFA134a. HFA152a sprays have a 23% reduction in Jakob number compared to HFA134a; plume width at the mouthpiece exit is commensurately increased by 40%. Equivalent HFO1234ze(E) sprays have less pronounced differences in Jakob number (13% reduced) and plume width (25% increased) compared to equivalent HFA134a sprays. Empirical models and standards which implicitly incorporate the flash-evaporation effects commonly observed in high-GWP HFA propellants may require adjustment to be suitable for use with low-GWP formulations.
Keywords: PMDI; flash-evaporation; low-GWP; spray pattern; suspension.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Newman SP. Principles of metered-dose inhaler design. Respir Care. 2005;50:1177–90. - PubMed
-
- Pritchard JN. The climate is changing for metered-dose inhalers and action is needed. Drug Des Devel Ther. 2022;14:3043–55. - DOI
-
- Intergovernmental Panel on Climate Change. Fourth Assessment Report. Geneva: United Nations; 2007.
-
- Newman B, Luke M. FDA perspectives on scientific and regulatory considerations for MDIs transitioning to a low global warming potential propellant. In: Dalby R, Peart J, Traini D, Young P, Suman J (eds) Proceedings of Respiratory Drug Delivery. 2024 RDD Online: Richmond; 2024.
-
- Buttini F, Glieca S, Sonvico F, Lewis DA. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen. Expert Opin Drug Deliv. 2023;17425247(2023):2264184.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources